Originally identified as a key regulator in acute DNA damage response, recent studies have uncovered additional TP53 downstream targets and pathways [92–95], including those related to stemness, metabolism, redox biology, genomic integrity, and tumor suppression through non-cell autonomous signaling [88,90,92,95]. This evidence concerns the gene TP53 and neoplasm.